Agronomics Limited

("Agronomics" or the "Company")

Announces the Trading Facility of Warrant Instrument

Agronomics, the leading listed investor focused on cellular agriculture, is pleased to announce that it has entered into an agreement with J P Jenkins Limited ("J P Jenkins") to facilitate the trading of warrants issued in connection with the Company's financing announced on 1 December 2021, on a matched bargain basis. Trading of the warrants is expected to commence on 23 March 2022.

The indicative pricing for these warrants (ISIN:IM00BP68CG25), as well as the transaction history will be available on the website https://jpjenkins.com/company/agronomics-warrants/. Warrant holders wishing to trade these securities can do so through their stockbroker.

Trades will be conducted at a level that JP Jenkins is able to match a willing seller and a willing buyer. Trades can be conducted and limits can be accepted during normal business hours by contacting JP Jenkins trading desk via STX 76086. Shareholders or potential investors can place limits via their existing UK regulated stockbroker.

For more information please contact J P Jenkins at info@jpjenkins.com or on +44 (0) 20 7469 0937.

About J P Jenkins

J P Jenkins is the well-known platform for dealing in unquoted securities. It provides a solution that enables companies to allow their existing shareholders and prospective investors to trade in their shares.

About Agronomics

Agronomics is a leading listed alternative proteins company with a focus on cellular agriculture and cultivated meat. The Company has established a portfolio of 21 companies at the Pre-Seed to Series C stage in this rapidly advancing sector. It seeks to secure minority stakes in companies owning technologies with defensible intellectual property that offer new ways of producing food and materials with a focus on products historically derived from animals. These technologies are driving a major disruption in agriculture, offering solutions to improve sustainability, as well as addressing human health, animal welfare and environmental damage. This disruption will decouple supply chains from the environment and animals, as well as being fundamental to feeding the world's expanding population. A full list of Agronomics' portfolio companies is available at https://agronomics.im/.

About Cellular Agriculture

Cellular Agriculture is the production of agriculture products directly from cells, as opposed to raising an animal for slaughter, or growing crops. This encompasses cell culture to produce cultivated meat and materials, and fermentation processes that harness a combination of molecular biology, synthetic biology, tissue engineering and biotechnology to massively simplify production methods in a sustainable manner.

Over the coming decades, the source of the world's food supply traditionally derived from conventional agriculture is going to change dramatically. We have already witnessed the first wave of this shift with the consumer adoption of plant-based alternative proteins but today, we are on the cusp of an even bigger wave of change. This is being facilitated by advances in cellular agriculture. This change is necessary, given scientists claims that if we maintain existing animal protein consumption patterns, then we will not meet the Paris Agreement's goal of limiting warming to 1.5℃

AT Kearney, a global consultancy firm, projects that cultivated meat's market share will reach 35% by 2040. This combined with the Good Food Institute's estimate that a US$ 1.8 trillion investment will be required in order to produce just 10% of the world's protein using this technology, means that we are on the cusp of a multi-decade flow of capital to build out manufacturing facilities. Funding in the field of cellular agriculture is accelerating, however still less than US$ 2 billion has been invested worldwide since the industry's inception in 2016.

For further information, please contact: